Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
- PMID: 29199115
- PMCID: PMC5805861
- DOI: 10.1016/S2213-8587(17)30362-5
Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank
Abstract
Background: Type 1 diabetes is typically considered a disease of children and young adults. Genetic susceptibility to young-onset type 1 diabetes is well defined and does not predispose to type 2 diabetes. It is not known how frequently genetic susceptibility to type 1 diabetes leads to a diagnosis of diabetes after age 30 years. We aimed to investigate the frequency and phenotype of type 1 diabetes resulting from high genetic susceptibility in the first six decades of life.
Methods: In this cross-sectional analysis, we used a type 1 diabetes genetic risk score based on 29 common variants to identify individuals of white European descent in UK Biobank in the half of the population with high or low genetic susceptibility to type 1 diabetes. We used Kaplan-Meier analysis to evaluate the number of cases of diabetes in both groups in the first six decades of life. We genetically defined type 1 diabetes as the additional cases of diabetes that occurred in the high genetic susceptibility group compared with the low genetic susceptibility group. All remaining cases were defined as type 2 diabetes. We assessed the clinical characteristics of the groups with genetically defined type 1 or type 2 diabetes.
Findings: 13 250 (3·5%) of 379 511 white European individuals in UK Biobank had developed diabetes in the first six decades of life. 1286 more cases of diabetes were in the half of the population with high genetic susceptibility to type 1 diabetes than in the half of the population with low genetic susceptibility. These genetically defined cases of type 1 diabetes were distributed across all ages of diagnosis; 537 (42%) were in individuals diagnosed when aged 31-60 years, representing 4% (537/12 233) of all diabetes cases diagnosed after age 30 years. The clinical characteristics of the group diagnosed with type 1 diabetes when aged 31-60 years were similar to the clinical characteristics of the group diagnosed with type 1 diabetes when aged 30 years or younger. For individuals diagnosed with diabetes when aged 31-60 years, the clinical characteristics of type 1 diabetes differed from those of type 2 diabetes: they had a lower BMI (27·4 kg/m2 [95% CI 26·7-28·0] vs 32·4 kg/m2 [32·2-32·5]; p<0·0001), were more likely to use insulin in the first year after diagnosis (89% [476/537] vs 6% [648/11 696]; p<0·0001), and were more likely to have diabetic ketoacidosis (11% [61/537] vs 0·3% [30/11 696]; p<0·0001).
Interpretation: Genetic susceptibility to type 1 diabetes results in non-obesity-related, insulin-dependent diabetes, which presents throughout the first six decades of life. Our results highlight the difficulty of identifying type 1 diabetes after age 30 years because of the increasing background prevalence of type 2 diabetes. Failure to diagnose late-onset type 1 diabetes can have serious consequences because these patients rapidly develop insulin dependency.
Funding: Wellcome Trust and Diabetes UK.
Copyright © 2018 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
Figures
Comment in
-
Genetics and biobanks converge to resolve a vexing knowledge gap in diabetes.Lancet Diabetes Endocrinol. 2018 Feb;6(2):87-89. doi: 10.1016/S2213-8587(17)30399-6. Epub 2017 Nov 30. Lancet Diabetes Endocrinol. 2018. PMID: 29199113 No abstract available.
-
Diabetes: Quantifying genetic susceptibility in T1DM - implications for diagnosis after age 30.Nat Rev Endocrinol. 2018 Feb 9;14(3):134-135. doi: 10.1038/nrendo.2018.7. Nat Rev Endocrinol. 2018. PMID: 29422635 No abstract available.
-
Genetic risk scores in adult-onset type 1 diabetes.Lancet Diabetes Endocrinol. 2018 Mar;6(3):168-169. doi: 10.1016/S2213-8587(18)30039-1. Lancet Diabetes Endocrinol. 2018. PMID: 29475495 No abstract available.
-
Genetic risk scores in adult-onset type 1 diabetes - Authors' reply.Lancet Diabetes Endocrinol. 2018 Mar;6(3):169. doi: 10.1016/S2213-8587(18)30046-9. Lancet Diabetes Endocrinol. 2018. PMID: 29475496 No abstract available.
Similar articles
-
DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life.Diabetologia. 2021 Oct;64(10):2258-2265. doi: 10.1007/s00125-021-05513-4. Epub 2021 Jul 16. Diabetologia. 2021. PMID: 34272580 Free PMC article.
-
A data-driven approach for studying the role of body mass in multiple diseases: a phenome-wide registry-based case-control study in the UK Biobank.Lancet Digit Health. 2019 Jul;1(3):e116-e126. doi: 10.1016/S2589-7500(19)30028-7. Epub 2019 Jun 27. Lancet Digit Health. 2019. PMID: 33323262
-
Associations of Combined Genetic and Lifestyle Risks With Incident Cardiovascular Disease and Diabetes in the UK Biobank Study.JAMA Cardiol. 2018 Aug 1;3(8):693-702. doi: 10.1001/jamacardio.2018.1717. JAMA Cardiol. 2018. PMID: 29955826 Free PMC article.
-
Homogeneity in the association of body mass index with type 2 diabetes across the UK Biobank: A Mendelian randomization study.PLoS Med. 2019 Dec 10;16(12):e1002982. doi: 10.1371/journal.pmed.1002982. eCollection 2019 Dec. PLoS Med. 2019. PMID: 31821322 Free PMC article.
-
The importance of diabetes registries and clinical biology for the study and treatment of type 1 (insulin-dependent) diabetes mellitus.Verh K Acad Geneeskd Belg. 1996;58(5):539-86. Verh K Acad Geneeskd Belg. 1996. PMID: 9008403 Review.
Cited by
-
The Human Islet: Mini-Organ With Mega-Impact.Endocr Rev. 2021 Sep 28;42(5):605-657. doi: 10.1210/endrev/bnab010. Endocr Rev. 2021. PMID: 33844836 Free PMC article. Review.
-
Importance of applying treatment data to ascertain type 1 diabetes cases in health registries.BMJ Open Diabetes Res Care. 2021 Apr;9(1):e002280. doi: 10.1136/bmjdrc-2021-002280. BMJ Open Diabetes Res Care. 2021. PMID: 33863717 Free PMC article. No abstract available.
-
Experimental study on physical exercise in diabetes: pathophysiology and therapeutic effects.Eur J Transl Myol. 2023 Oct 10;33(4):11560. doi: 10.4081/ejtm.2023.11560. Eur J Transl Myol. 2023. PMID: 37817671 Free PMC article.
-
Virus Infection Is an Instigator of Intestinal Dysbiosis Leading to Type 1 Diabetes.Front Immunol. 2021 Oct 15;12:751337. doi: 10.3389/fimmu.2021.751337. eCollection 2021. Front Immunol. 2021. PMID: 34721424 Free PMC article. Review.
-
Extracellular Vesicles Derived Human-miRNAs Modulate the Immune System in Type 1 Diabetes.Front Cell Dev Biol. 2020 Mar 31;8:202. doi: 10.3389/fcell.2020.00202. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 32296701 Free PMC article.
References
-
- Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2015. 2015. http://diabetesinscotland.org.uk/Publications/SDS2015.pdf (accessed June 15, 2017).
-
- Farmer A, Fox R. Diagnosis, classification, and treatment of diabetes. BMJ. 2011;342:d3319. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical